Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART27.13 for cancer anorexia and weight loss
ISRCTN15607817Phase 2Active, not recruiting
- Sponsor
- Artelo Biosciences
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of AZD-1940 in anorexia nervosa (AN) and cancer anorexia-cachexia syndrome (CACS) (6 arms), sponsored by Artelo Biosciences. Primary endpoints: Safety, Change in lean body mass and 1 more. Started Mar 2021; status: active, not recruiting.
02
Drugs
AZD-1940
03
Conditions
anorexia nervosa (AN)cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on ISRCTN15607817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15607817.